Physician profile
Ronald L Sherman
NPI 1780773226
$7,318.44
in general payments reported to CMS, 2019-2025
8 companies · $2,491 in 2025
The $2,491 reported for 2025 was more than what 96% of Foot Surgery providers received nationally (typical 2025 total: $180).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $123 · 2021: $1,663 · 2023: $73.76 · 2024: $2,967 · 2025: $2,491.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $2,500 · Travel and Lodging: $1,382 · Food and Beverage: $1,220 · Consulting Fee: $413 · Education: $18.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $2,500.00 |
| Travel and Lodging | $1,382.31 |
| Food and Beverage | $1,219.71 |
| Consulting Fee | $412.50 |
| Education | $18.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kerecis Limited | $2,870.96 | 2024-2025 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Surgiclose |
| Integra Lifesciences Corporation | $2,069.67 | 2021-2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Mimedx Group, INC. | $1,201.59 | 2025 | |
| Smith+Nephew, INC. | $528.96 | 2024-2025 | Grafix, Grafix Pl, Grafix Xc |
| Stryker Corporation | $450.08 | 2025 | Clottriever Bold Catheter, Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Medline Industries Lp | $123.42 | 2019 | |
| Orpyx Medical Technologies US INC. | $55.76 | 2023 | Orpyx Si |
| Kci USA, INC. | $18.00 | 2023 | Prevena |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ronald Sherman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.